Company intelligence / Profile preview

Robotrak Technologies

Nanjing, Jiangsu, China

Ownership: Private
Employees: ~160
Development stage: Other

Overview

Robotrak has developed the world's first commercial-grade AO-SLO single-cell retinal imaging system and China's first intelligent fundus navigation laser robot. Its Mona Adaptive Optics Retinal Imaging System enables high-resolution cellular-level retinal imaging for clinical research. The company's products are used by hospitals, research institutes, and pharmaceutical companies globally. In 2024, their flagship device received NMPA registration in China.

Therapeutic areas: Ophthalmology
Modalities: DeviceDigital health technology
Industry: Medical Imaging

Partnerships

Academic partnerships with University of Washington Visual Research Center/Sabesan Lab for clinical validation of adaptive optics technologySupplies to multiple hospitals/research institutions/pharma companies worldwide

Beyond the preview

Go deeper on Robotrak Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robotrak Technologies.

Explore the full profile